KRAS mutant lung cancer: progress thus far on an elusive therapeutic target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KRAS mutant lung cancer: progress thus far on an elusive therapeutic target

Published:2015-12 Issue:1 Volume:4 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Bhattacharya Saveri¹,Socinski Mark A.²,Burns Timothy F.³

Affiliation:

1. University of Pittsburgh Cancer Institute5150 Centre Avenue, Room 46115232PittsburghPAUSA

2. Medicine and Cardiothoracic SurgeryUniversity of Pittsburgh Cancer Institute5150 Centre Avenue, Room 55615232PittsburghPAUSA

3. University of Pittsburgh Cancer Institute5117 Centre Avenue, Office: Suite 2.18e15232PittsburghPAUSA

Funder

LUNGevity Foundation

V Foundation for Cancer Research

Sidney Kimmel Foundation for Cancer Research

Doris Duke Charitable Foundation

National Cancer Institute

V Foundation

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/s40169-015-0075-0

Reference55 articles.

1. Cancer statistics, 2015

2. Personalized treatment of EGFR mutant and ALK-positive patients in NSCLC

3. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

4. Personalized Medicine in Non–Small-Cell Lung Cancer: IsKRASa Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?

5. Ras oncogenes: split personalities

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma;Cureus;2024-02-08

2. Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review;International Journal of Molecular Sciences;2023-07-27

3. Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: A case report and literature review;Medicine;2022-12-09

4. Contribution of prognostic ferroptosis-related subtypes classification and hub genes of sepsis;Transplant Immunology;2022-10

5. Does Molecular Profiling of KRAS-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?;Current Oncology;2022-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3